unknown
Stage
1
Investors
About
inBiome develops Molecular Culture technology that enables same-day bacterial identification directly from blood to accelerate diagnostics and improve treatment decisions in sepsis and other infectious diseases.
Explore inBiome's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.